SYMETRYX CORP sold 30.5% of their position (207.07K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market sale worth $336.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/11/2023ACC: 0001991925-23-000003
-207.07K
Net shares
Net seller
$336.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
207.07K disposed
Non-Derivative Transactions3
Common Stock, Par Value $0.0001 per Share
Direct
Shares
−74.85K
Price / share
$1.80
Trade value
$134.73K
% of position
11.0%
9/7/2023
680K→605.15K
Common Stock, Par Value $0.0001 per Share
Direct
Shares
−128.85K
Price / share
$1.53
Trade value
$197.14K
% of position
21.3%
9/8/2023
605.15K→476.30K
Common Stock, Par Value $0.0001 per Share
Direct
Shares
−3.38K
Price / share
$1.44
Trade value
$4.86K
% of position
0.7%
9/11/2023
476.30K→472.93K
Total
Net shares
−207.07K
Net value
-$336.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 per Share Direct | 9/7/2023 | S · Sale | −74.85K | $1.80 | $134.73K | 11.0% | 680K | 605.15K |
| Common Stock, Par Value $0.0001 per Share Direct | 9/8/2023 | S · Sale | −128.85K | $1.53 | $197.14K | 21.3% | 605.15K | 476.30K |
| Common Stock, Par Value $0.0001 per Share Direct | 9/11/2023 | S · Sale | −3.38K | $1.44 | $4.86K | 0.7% | 476.30K | 472.93K |
| Total | −207.07K | -$336.73K | ||||||
Derivative Transactions0
No derivative transactions reported